- Home
- RVPH vs NTIP Comparison
RVPH vs NTIP Comparison
Compare RVPH & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- NTIP
- Stock Information
- Founded
- RVPH 2006
- NTIP 1990
- Country
- RVPH United States
- NTIP United States
- Employees
- RVPH N/A
- NTIP N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- RVPH Health Care
- NTIP Miscellaneous
- Exchange
- RVPH Nasdaq
- NTIP Nasdaq
- Market Cap
- RVPH 32.8M
- NTIP 28.6M
- IPO Year
- RVPH N/A
- NTIP 1998
- Fundamental
- Price
- RVPH $0.40
- NTIP $1.35
- Analyst Decision
- RVPH Strong Buy
- NTIP
- Analyst Count
- RVPH 5
- NTIP 0
- Target Price
- RVPH $9.00
- NTIP N/A
- AVG Volume (30 Days)
- RVPH 3.1M
- NTIP 15.9K
- Earning Date
- RVPH 08-13-2025
- NTIP 08-11-2025
- Dividend Yield
- RVPH N/A
- NTIP 8.00%
- EPS Growth
- RVPH N/A
- NTIP N/A
- EPS
- RVPH N/A
- NTIP N/A
- Revenue
- RVPH N/A
- NTIP $250,000.00
- Revenue This Year
- RVPH N/A
- NTIP N/A
- Revenue Next Year
- RVPH N/A
- NTIP N/A
- P/E Ratio
- RVPH N/A
- NTIP N/A
- Revenue Growth
- RVPH N/A
- NTIP N/A
- 52 Week Low
- RVPH $0.30
- NTIP $1.16
- 52 Week High
- RVPH $4.28
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- NTIP 59.32
- Support Level
- RVPH $0.35
- NTIP $1.20
- Resistance Level
- RVPH $0.83
- NTIP $1.30
- Average True Range (ATR)
- RVPH 0.06
- NTIP 0.06
- MACD
- RVPH -0.01
- NTIP 0.01
- Stochastic Oscillator
- RVPH 17.36
- NTIP 84.44
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.